Asymchem announced the appointment of Franck Mevellec as senior director, business development. Franck brings over 20 years of experience in the pharmaceutical industry, working across various aspects of drug development from R&D to sales. Franck boasts a proven track record of success, having held key positions at industry leaders like Bayer Healthcare (R&D), Teva Pharmaceuticals (portfolio director), Minakem (BD director), and most recently, Seqens (global head of sales). He joins Asymchem with a focus on expanding the company?s footprint across Europe.
In his new role, Franck will leverage his expertise to develop new business opportunities for Asymchem, focusing on a wide range of services including flow chemistry, oligo and peptides, drug product development, and biologics.